A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.

The navies of Mexico and El Salvador announced big drug seizures in the Pacific Ocean this week of more than 10 tons of cocaine, in contrast to deadly strikes by the U.S. government that just this ...

When is the Sims 4 Royalty and Legacy release time? It's that time of the year again, the next big expansion for Sims 4 is here. This time, your sims can step into the shoes of nobility, kings, queens ...

In recent months, The Sims 4 has been ramping up its login reward events and limited-time challenges. Login rewards are what they sound like: Hop into the game for a certain number of days, and unlock ...

The Sims 4 Royalty & Legacy Expansion Pack is set in a beautiful world filled with opportunities for drama and storytelling, and a generous inclusion of older lore had the Sims 2 fan in me absolutely ...

If you're a dedicated The Sims player, you've likely heard of one of the game's most taboo but oh-so popular mods: Wicked Whims. First released nearly a decade ago, the adult-oriented mod adds some ...

One of The Sims 4's biggest mods is putting up numbers a triple-A game would be jealous of. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

Here we are again trying to divine the future of The Sims from an announcement about the future of The Sims. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

Given the size of the opportunity, the competition is fierce. In fall 2025, another publicly traded obesity drug upstart called Metsera became the object of an intense bidding war between Novo and ...

The 100 Base Game Traits mod for The Sims 4 introduces a massive collection of unique personality traits that expand your Sims’ individuality and interactions. From quirky habits to deep emotional ...

Deck the Palms is the final time-limited event to take place in The Sims 4 in 2025, and as the name (lightly) suggests, there's a bit of a double theme at play here. Yes, it's another Christmas event ...

A closer look at phase 3 data on BioNTech and OncoC4’s anti-CTLA-4 antibody has shown the efficacy that excited analysts last week is offset by a challenging tolerability profile. Analysts got an ...